References
- De Leo V, la Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 2003; 24: 633–667
- Barbieri R L, Makris A, Randall R W, Daniels G, Kistner R W, Ryan K J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 1986; 62: 904–910
- Suikkari A M, Ruutiainen K, Erkkola R, Seppala M. Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum Reprod 1989; 4: 136–139
- Fulghesu A M, Villa P, Pavone V, Guido M, Apa R, Caruso A, Lanzone A, Rossodivita A, Mancuso S. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 644–648
- De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999; 72: 282–285
- Dale P O, Tanbo T, Haug E, Abyholm T. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum Reprod 1998; 13: 567–570
- Homburg R, Orvieto R, Bar-Hava I, Ben-Rafael Z. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome. Hum Reprod 1996; 11: 716–719
- Poretsky L, Cataldo N A, Rosenwaks Z, Giudice L C. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999; 20: 535–582
- Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991; 12: 3–13
- Dale O, Tanbo T, Lunde O, Abyholm T. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome. Acta Obstet Gynecol. Scand 1993; 72: 43–46
- La Marca A, Egbe T O, Morgante G, Paglia T, Cianci A, De Leo V, Cianci A. Metformin treatment reduces ovarian cytochrome P-450c17α response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome. Hum Reprod 2000; 15: 21–23
- La Marca A, Morgante G, Palumbo M, Cianci A, Petraglia F, De Leo V. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril 2002; 78: 1234–1239
- Fedorcsák P, Dale P O, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland A K, Åbyholm T, Tanbo T. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004; 19: 2523–2528
- Steinkampf M P, Hammond K R, Nichols J E, Slayden S H. Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration. Fertil Steril 2003; 80: 99–102